Please login to the form below

Not currently logged in
Email:
Password:

Akari Therapeutics strengthens board

Hires Michael Grissinger and Dr Peter Feldschreiber

Mike GrissingerBiopharmaceutical company Akari Therapeutics has bolstered its board of directors with the addition of Michael Grissinger and Dr Peter Feldschreiber.

Grissinger (pictured right) has spent 22 years at Johnson & Johnson, holding positions of vice president and head of worldwide pharmaceutical licencing, as well as vice president and head of worldwide pharmaceutical corporate development and M&A.

His expertise has seen him led transactions across a broad span of deal-types, geographies, and therapeutic disease areas and he brings experience in business and corporate development, finance, marketing and strategic planning to Akari.

Alongside Grissinger, Dr Peter Feldschreiber also joins the board bringing 20 years’ experience in the pharmaceutical industry.

He has held appointments as senior medical assessor and special litigation coordinator to the healthcare products regulatory agency.

Ray Prudo, executive chairman of Akari Therapeutics, said: “We are pleased to strengthen our board with two individuals that bring such a range and depth of healthcare industry experience.

“As Akari continues its mission to develop and commercialise treatments for orphan autoimmune and inflammatory disease, we look forward to benefitting from Michael’s expertise as a successful business and corporate development leader and Peter’s insight as a medical doctor with experience both in the pharmaceutical industry and the legal and regulatory aspects of healthcare.”

31st January 2018

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Streaming Well

Streaming Well is a healthcare focused, award-winning video production company which operates in the US and Europe....

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics